期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血清超敏C反应蛋白高含量脑梗死患者应用辛伐他汀的意义 被引量：3

下载PDF
导出
摘要 目的探讨血清超敏C反应蛋白(HS-CRP)高含量急性脑梗死患者中应用辛伐他汀的意义。方法将70例血清HS-CRP增高脑梗死患者随机分两组,观察组共37例,常规治疗加服辛伐他汀20 mg每晚1次;对照组共33例,常规治疗加服安慰剂三维B片每晚1次,共治疗14 d。两组治疗前及第21天均评定神经功能改善情况。结果入院后第21天,观察组神经功能缺损评分(16.21±5.68)分明显低于对照组的(23.55±6.29)分(P<0.01),总有效率观察组为86.49%,较对照组的63.64%显著提高(P=0.026);结论辛伐他汀能够明显改善血清高敏C反应蛋白高含量急性脑梗死患者神经功能缺损。
作者 黄毓华 刘铭
机构地区 广东省潮州市人民医院神经内科
出处 《广东医学》 CAS CSCD 北大核心 2010年第24期3267-3268,共2页 Guangdong Medical Journal
关键词 脑梗死 超敏C反应蛋白 辛伐他汀 神经功能缺损
分类号 R544.1 [医药卫生—心血管疾病]
  • 相关文献

参考文献6

二级参考文献10

  • 1曹红,孙长凯,赵杰,赵耿毅,唐树良,汪秋艳,侯宇,许晶,陶定波,刘新胜,黄爱莉.他汀类药物对脑梗死患者神经功能缺损及血清相关参数的影响[J].中国临床康复,2005,9(9):94-96. 被引量：25
  • 2Chan Carusone S, Smieja M, Molloy W, et al. Lack of association between vascular dementia and Chlamydia pneumoniae infection: a case-control study. BMC Neurol 2004;4(1): 15
  • 3Hashimoto H, Kitagawa K, Hougaku H, et al. Relationship between C-reactive protein and progression of early carotid atherosclerosis in hypertensive subjects. Stroke 2004; 35 (7) : 1625 - 30
  • 4Patrick L, Uzick M. Cardiovascular disease: C-reactive protein and the inllammatory disease paradigm: HMG-CoA n~ductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature. Altern Med Rev 2001; 6(3):248 -71
  • 5Yasojima K, Schwab C, McGeer EG, et al. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 2001; 158(3):1039 -51
  • 6Tohgi H, Konno S, Takahashi S, et al. Activated coagulation/fibrinolysis system and platelet function in acute thrombotic stroke patients with increased C-reactive protein.levels. Thromb Res 2000; 100(5): 373 -9
  • 7Plehn JF, Davis BR, Sacks FM, et al. Reduction of stroke incidence alter myocardial infarction with pravastatin: the Cholesterol and Recurrent Events(CARE)study. The Care Investigators. Circulation 1999;99(2): 216 - 23
  • 8Hess DC, Demchuk AM, Brass LM, et al. HMG-CoA reductase inhibitors(statins): a promising approach to stroke prevention. Neurology 2000; 54(4):790 - 6
  • 9Karaca I, llkay E, Akbulut M, et al. Atorvastatin affects C-reactive protein levels in patients with coronary artery disease. Curr Med Res Opin 2003; 19 (3): 187 -91.
  • 10Lee KT, Lai WT, Chu CS, et al. Effect of withdrawal of statin on C-reactive protein.Gardiology.2004; 102(3.):166-70

共引文献42929

同被引文献22

  • 1于艳秋,张兰.阿托伐他汀治疗老年脑梗死患者炎症反应的临床疗效[J].广东医学,2005,26(12):1726-1727. 被引量：7
  • 2BARBER M, LANGHOME P, RUMLEY A, et al. Hemostatic function and progressing ischemic stroke : D - dimer predicts early clinical progression[ J]. Stroke, 2004, 35 (6) : 1421 - 1425.
  • 3TOUBOUL P J, HENNERICI M G, MEAIRS S, et al. Mannheim carotid intima - media thickness consensus ( 2004--2006 ). An update on behalf of the Advisory Board of the 3rd and 4th Watc- hing the Risk Symposium, 13th and 15th European Stroke Confe- rences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006 [ J ]. Cerebrovasc Dis, 2007, 23 ( 1 ) : 75 - 80.
  • 4CROUSE J R, GROBBEE D E, O'LEARY D H, et al. Carotid intima - media thickness in low - risk individuals with asympto- matic atherosclerosis: baseline data from the METEOR study[ J]. Curr Med Res Opin, 2007, 23(3) : 641 -648.
  • 5OIS A, MARTINEZ RODRIGUEZ J E, MUNTEIS E, et al. Steno - occlusive arterial disease and early neurological deterioration inacute isehemic stroke [ J ]. Cerebrovasc Dis, 2008, 25 ( 1/2 ) : 151 - 156.
  • 6SWETS J A. Measuring the accuracy of diagnostic systems [ J ]. Science, 1988, 240(4857) : 1285 - 1293.
  • 7ROTHWELL P M. Limitations of the usual blood - pressure hy- pothesis and importance of variability, instability, and episodic hypertension[J]. Lancet, 2010, 375(9718): 938-948.
  • 8ROTHWELL P M, HOWARD S C, DOLAN E, et al. Prognostic significance of visit - to - visit variability, maximum systolic blood pressure, and episodic hypertension [ J]. Lancet, 2010, 375 (9718) : 895 -905.
  • 9FISHER M, MOONIS M. Neuroprotective effects of statins: evi- dence from preclinical and clinical studies[ J]. Curt Treat Options Cardiovasc Med, 2012, 14(3): 252-259.
  • 10FLINT A C, KAMEL H, NAVI B B, et al. Statin use during is- chemic stroke hospitalization is strongly associated with improved poststroke survival[ J]. Stroke, 2012, 43 ( 1 ) : 147 - 154.

引证文献3

二级引证文献22

广东医学
2010年 第24期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部